Fluticasone Furoate And Vilanterol Powder
Product Images NDC 66993-135

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Fluticasone Furoate And Vilanterol (NDC 66993-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Furoate Chemical Structure (Ff Vil Spl Graphic 01)

FDA Label Image

Vilanterol Chemical Structure (Ff Vil Spl Graphic 02)

FDA Label Image

Figure 1 (Ff Vil Spl Graphic 03)

FDA Label Image

Figure 2 (Ff Vil Spl Graphic 04)

This appears to be a table showing interactions between two drugs - Ketoconazole and Verapamil. The table includes a "Fold Change" column, and some percentages and values but it is not clear what they refer to. The table also includes the recommendation to exercise caution and to not adjust the dose without consulting a healthcare provider.*

FDA Label Image

Figure 3 (Ff Vil Spl Graphic 05)

FDA Label Image

Figure 3 (Ff Vil Spl Graphic 06)

FDA Label Image

Figure 4 Day 1 (Ff Vil Spl Graphic 07)

FDA Label Image

Figure 4 Day 168 (Ff Vil Spl Graphic 08)

Not available. It appears to be an incomplete chart or graph.*

FDA Label Image

Figure 5 Day 1 (Ff Vil Spl Graphic 09)

Not available.*

FDA Label Image

Figure 5 Day 28 (Ff Vil Spl Graphic 10)

FDA Label Image

Figure 6 (Ff Vil Spl Graphic 11)

FDA Label Image

Figure 7 (Ff Vil Spl Graphic 12)

This appears to be a graph showing the LS Mean Change from Baseline in milliliters over time since dose in hours for three different treatments: Fluticasone furoate/vilanterol 100mcg/25mcg, Fluticasone furoate/vilanterol 200mcg/25mcg, and Fluticasone furoate 100mcg using ELLIPTA.*

FDA Label Image

Fluticasone Furoate/vilanterol Ellipta Inhaler (Ff Vil Spl Graphic 13)

FDA Label Image

Figure A (Ff Vil Spl Graphic 14)

FDA Label Image

Figure B (Ff Vil Spl Graphic 15)

FDA Label Image

Figure C (Ff Vil Spl Graphic 16)

FDA Label Image

Figure D (Ff Vil Spl Graphic 17)

FDA Label Image

Figure E (Ff Vil Spl Graphic 18)

FDA Label Image

Figure F (Ff Vil Spl Graphic 19)

FDA Label Image

Figure G (Ff Vil Spl Graphic 20)

This text is a warning message advising against blocking the air vent with one's fingers.*

FDA Label Image

Figure H (Ff Vil Spl Graphic 21)

FDA Label Image

Figure I (Ff Vil Spl Graphic 22)

FDA Label Image

Figure J (Ff Vil Spl Graphic 23)

FDA Label Image

Figure K (Ff Vil Spl Graphic 24)

FDA Label Image

Figure L (Ff Vil Spl Graphic 25)

FDA Label Image

Fluticasone Furoate-vilanterol Ellipta 100 Mcg-25mcg Carton (Ff Vil Spl Graphic 26)

NDC 66993-135-97 is the code for Fluticasone Furoate/Vilanterol ELLIPTA Inhalation Powder for oral inhalation only. It comes in an inhaler containing 30 doses and contains 2 foil strips of 30 blisters each. One strip contains 100 meg of fluticasone furoate and lactose monohydrate while the other strip contains 25 mcg of vilanterol, magnesium stearate, and lactose monohydrate. It is meant for prescription only.*

FDA Label Image

Fluticasone Furoate-vilanterol Ellipta 200mcg-25mcg Carton (Ff Vil Spl Graphic 27)

NDC 66993-136-97 is a prescription medication in the form of Fluticasone Furoate/Vilanterol ELLIPTA Inhalation Powder for oral inhalation. It contains two separate foil strips. One strip contains 30 blisters where each blister contains 200 mcg of fluticasone furoate and lactose monohydrate, while the other strip contains 30 blisters where each blister contains 25 mcg of vilanterol, magnesium stearate, and lactose monohydrate. Its package comes with an ELLIPTA inhaler containing 30 doses, 60 blisters in total.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.